ETI Shows Minimal Bone Health Impact in Cystic Fibrosis



Elexacaftor-tezacaftor-ivacaftor combination therapy shows no clinically meaningful improvement in bone health or calcium metabolism in patients with cystic fibrosis, a Danish study shows.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/elexacaftor-tezacaftor-ivacaftor-therapy-shows-minimal-2026a1000792?src=rss

Author :

Publish date : 2026-03-10 07:58:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version